Amit Mathur, MD, Maher Baz, MD, E

Slides:



Advertisements
Similar presentations
Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,
Advertisements

Perioperative Statin Therapy for Patients Undergoing Coronary Artery Bypass Grafting  Amr F. Barakat, MD, Marwan Saad, MD, PhD, Ahmed Abuzaid, MD, Amgad.
Repeat Sternotomy: No Longer a Risk Factor in Mitral Valve Surgical Procedures  Mehrdad Ghoreishi, MD, Murtaza Dawood, MD, Gerald Hobbs, PhD, Chetan Pasrija,
Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up  Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,
Perioperative Statin Therapy for Patients Undergoing Coronary Artery Bypass Grafting  Amr F. Barakat, MD, Marwan Saad, MD, PhD, Ahmed Abuzaid, MD, Amgad.
Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease  Jan Müller, PhD, Pinar Bambul Heck, MD, Peter Ewert,
Oral Sildenafil Reduces Pulmonary Hypertension After Cardiac Surgery
Salah Sabbagh, MD, Michele M. Henry Salzman, BS, Robert A
Trevor Williams, MD, MPH, Brian C
A Closed Perfusion System With Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients  Lena Lindholm,
Extent of Aortic Coverage and Incidence of Spinal Cord Ischemia After Thoracic Endovascular Aneurysm Repair  Robert J. Feezor, MD, Tomas D. Martin, MD,
Minimally Invasive Extracorporeal Bypass in Minimally Invasive Heart Valve Operations: A Prospective Randomized Trial  Hardy Baumbach, MD, Christian J.
Andrew D. Shaw, MB, Ara A. Vaporciyan, MD, Xifeng Wu, MD, Terri M
The Society of Thoracic Surgeons Thoracic Surgery Practice and Access Task Force: 2014 Workforce Report  John S. Ikonomidis, MD, PhD  The Annals of Thoracic.
Atrial Fibrillation After Coronary Artery Bypass Grafting Surgery: Development of a Predictive Risk Algorithm  Mitchell J. Magee, MD, Morley A. Herbert,
Right Gastroepiploic Artery Graft for Myocardial Revascularization: Prevalence of Atherosclerosis and Availability as a Conduit  Kwang Ree Cho, MD, PhD,
The Annals of Thoracic Surgery
Simple Index to Predict Likelihood of Skilled Nursing Facility Admission After Coronary Artery Bypass Grafting Among Older Patients  David C. Chang, PhD,
Simvastatin Increases Neutrophil Apoptosis and Reduces Inflammatory Reaction After Coronary Surgery  Massimo Chello, MD, Amedeo Anselmi, MD, Cristiano.
Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD 
Trevor Williams, MD, MPH, Brian C
Dexamethasone Pretreatment Provides Antiinflammatory and Myocardial Protection in Neonatal Arterial Switch Operation  Ruth Heying, MD, PhD, Edith Wehage,
Dissecting Multidisciplinary Cardiac Surgery Rounds
William T. Mahle, MD, Emilia Matthews, MS, Kirk R. Kanter, MD, Brian E
Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass  Martin Strüber, MD, Jochen T Cremer, MD, Bernhard.
Intraoperative Temperature Control Using the Thermogard System During Off-pump Coronary Artery Bypass Grafting  Gary S. Allen, MD  The Annals of Thoracic.
Mariano E. Brizzio, MD, Alex Zapolanski, MD, Richard E
Who Do You Say You Are? The Annals of Thoracic Surgery
Relationship Between Antiinflammatory Cytokine Interleukin-10 and Lactate Concentrations in Neonates Undergoing the Arterial Switch Operation  Kyrylo.
Use of Amiodarone After Major Lung Resection
Anomalous Origin of Left Pulmonary Artery From Left Subclavian Artery
Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response  Martin Westerberg, MD, Anders.
Lei Yu, MD, Tianxiang Gu, MD, PhD, Zongyi Xiu, MD, PhD 
Karen L. Walker, MHS, Jonathan J. Shuster, PhD, Tomas D
Lung Function and ECMO After Lung Transplantation
Outcomes of Delayed Chest Closure After Bilateral Lung Transplantation
Hybrid Management of a Giant Left Main Coronary Artery Aneurysm
Percutaneous Transcatheter Closure of the Aortic Valve
Repeat Sternotomy: No Longer a Risk Factor in Mitral Valve Surgical Procedures  Mehrdad Ghoreishi, MD, Murtaza Dawood, MD, Gerald Hobbs, PhD, Chetan Pasrija,
Bradford B. Smith, MD, Matthew A
Severe Two-Vessel Ostial Stenosis of the Main Coronary Arteries in a Patient With Transposition of the Great Arteries After an Arterial Switch Operation 
Hypothermic Low-Flow Cardiopulmonary Bypass Impairs Pulmonary and Right Ventricular Function More Than Circulatory Arrest  Jess M. Schultz, MD, Tara Karamlou,
Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor
Current Assessment of Mortality Rates in Congenital Cardiac Surgery
Off-Pump Coronary Artery Bypass Disproportionately Benefits High-Risk Patients  John D. Puskas, MD, Vinod H. Thourani, MD, Patrick Kilgo, MS, William Cooper,
Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery  Karl F. Welke, MD, Mitchell J. Barnett, PharmD,
Sune Damgaard, MD, PhD, Claus H. Nielsen, MD, PhD, Lars W
Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction  Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),
Philip A. Linden, MD, Jon O. Wee, MD, Michael T
First Report on 30-day and Operative Mortality in Risk Model of Isolated Coronary Artery Bypass Grafting in Japan  Noboru Motomura, MD, PhD, Hiroaki Miyata,
Invited Commentary The Annals of Thoracic Surgery
Functional and Physiologic Results of Video-Assisted Thoracoscopic Diaphragm Plication in Adult Patients With Unilateral Diaphragm Paralysis  Richard.
Robert Lee Replogle, September 30, 1931–May 9, 2016
Aprotinin is Not Associated With Postoperative Renal Impairment After Primary Coronary Surgery  Gabriella Lindvall, MD, Ulrik Sartipy, MD, PhD, Torbjörn.
Pulmonary Embolectomy for Acute Massive Pulmonary Embolism
The American Board of Thoracic Surgery: Update
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Systemic Inflammation After On-Pump and Off-Pump Coronary Bypass Surgery: A One- Month Follow-Up  Alessandro Parolari, MD, PhD, Marina Camera, Biol Sci,
Håvard Nordgaard, MD, Nicola Vitale, MD, PhD, Rune Haaverstad, MD, PhD 
Induction of Interleukin-19 and Interleukin-22 After Cardiac Surgery With Cardiopulmonary Bypass  Chung-Hsi Hsing, MD, Mei-Yi Hsieh, MS, Wei-Yu Chen,
Predicting Early Coronary Artery Bypass Graft Failure by Intraoperative Transit Time Flow Measurement  Yoshiyuki Tokuda, MD, Min-Ho Song, MD, PhD, Yuichi.
Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients  Staffan Bjessmo, MD,
Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS 
Mark I. Block, MD  The Annals of Thoracic Surgery 
Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery  Chuntao Wu, MD, PhD, Edward L. Hannan,
An Assay to Monitor Bivalirudin Levels on Cardiopulmonary Bypass
Reduced Cytokines Release and Myocardial Damage in Coronary Artery Bypass Patients Due to L-Arginine Cardioplegia Supplementation  Luisa Colagrande, MD,
Location of the Second Internal Mammary Artery Graft Does Not Influence Outcome of Coronary Artery Bypass Grafting  Paul A. Kurlansky, MD, Ernest A. Traad,
How I Teach Hemi-Arch Replacement
Myocardial, Inflammatory, and Stress Responses in Off-Pump Coronary Artery Bypass Graft Surgery With Thoracic Epidural Anesthesia  Massimo Caputo, MD,
Presentation transcript:

Cytokine Profile After Lung Transplantation: Correlation With Allograft Injury  Amit Mathur, MD, Maher Baz, MD, E. Denmark Staples, MD, Mark Bonnell, MD, Jerry M. Speckman, MD, Phillip J. Hess, MD, Charles T. Klodell, MD, Daniel G. Knauf, MD, Lyle L. Moldawer, PhD, Thomas M. Beaver, MD  The Annals of Thoracic Surgery  Volume 81, Issue 5, Pages 1844-1850 (May 2006) DOI: 10.1016/j.athoracsur.2005.11.053 Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Experimental design. (ELISA = enzyme-linked immunoassay; h = hour; IL = interleukin; PA = pulmonary arterial; PGF = primary graft failure; PLTRE = post–lung transplant reperfusion edema; SA = systemic arterial; TNF-α = tumor necrosis factor alpha.) The Annals of Thoracic Surgery 2006 81, 1844-1850DOI: (10.1016/j.athoracsur.2005.11.053) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Interleukin-6 (IL-6) appearance in patients with clinically severe (PGF; n = 4), moderate (PLTRE; n = 6), and no allograft reperfusion injury (n = 11). (Diamonds = PGF SA; squares = PGF PA; triangles = PLTRE SA; X = PLTRE PA; X with hatch mark = no injury SA; X in box = no injury PA.) *Indicates statistically distinct profile of patients with PGF over PLTRE and no allograft reperfusion injury (p < 0.01). (h = hours; PA = pulmonary arterial; PGF = primary graft failure; PLTRE = post–lung transplant reperfusion edema; SA = systemic arterial.) The Annals of Thoracic Surgery 2006 81, 1844-1850DOI: (10.1016/j.athoracsur.2005.11.053) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Interleukin-8 (IL-8) appearance in patients with clinically severe (PGF; n = 4), moderate (PLTRE; n = 6), and no allograft reperfusion injury (n = 11). (Diamonds = PGF SA; squares = PGF PA; triangles = PLTRE SA; X = PLTRE PA; X with hatch mark = no injury SA; X in box = no injury PA.) *Indicates statistically distinct profile of patients with PGF over PLTRE and no allograft reperfusion injury (p < 0.01). (h = hours; PA = pulmonary arterial; PGF = primary graft failure; PLTRE = post–lung transplant reperfusion edema; SA = systemic arterial.) The Annals of Thoracic Surgery 2006 81, 1844-1850DOI: (10.1016/j.athoracsur.2005.11.053) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Interleukin-10 (IL-10) appearance in patients with clinically severe (PGF; n = 4), moderate (PLTRE; n = 6), and no allograft reperfusion injury (n = 11). (Diamonds = PGF SA; squares = PGF PA; triangles = PLTRE SA; X = PLTRE PA; X with hatch mark = no injury SA; X in box = no injury PA.) *Indicates statistically distinct profile of patients with PGF over PLTRE and no allograft reperfusion injury (p < 0.01). (h = hours; PA = pulmonary arterial; PGF = primary graft failure; PLTRE = post–lung transplant reperfusion edema; SA = systemic arterial.) The Annals of Thoracic Surgery 2006 81, 1844-1850DOI: (10.1016/j.athoracsur.2005.11.053) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 5 Interleukin-6 (IL-6) appearance in the 6 lung transplant recipients who were placed on cardiopulmonary bypass (CPB). (Diamonds = PGF SA; squares = PGF PA; triangles = PLTRE SA; X = PLTRE PA; X with hatch mark = no injury SA; X in box = no injury PA.) (h = hours; PGF = primary graft failure [n = 4]; PLTRE = post–lung transplant reperfusion edema [n = 1]; no injury [n = 1].) The Annals of Thoracic Surgery 2006 81, 1844-1850DOI: (10.1016/j.athoracsur.2005.11.053) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions